Abstract
Brain metastases (BM) are frequent in non-small cell lung cancer (NSCLC) patients, but there is a lack of evidence-based management of this patient group. We aimed to capture a snapshot of routine BM management in Europe to identify relevant research questions for future clinical trials. An EORTC Lung Cancer Group (LCG) online survey containing questions on NSCLC BM screening and treatment was distributed between 16/02/17 and 15/06/17 to worldwide EORTC LCG members, and through several European scientific societies in the thoracic oncology field. A total of 462 European physician responses (394 institutions) were analysed (radiation oncologist: 53% [n = 247], pulmonologist: 26% [n = 119], medical oncologist: 18% [n = 84]; 84% with >5 years' experience in NSCLC). Italy (18%, n = 85), Netherlands (15%, n = 68), UK (14%, n = 66), and France (12%, n = 55) contributed most. 393 physicians (85%) screened neurologically asymptomatic patients for BM at diagnosis (52% using magnetic resonance imaging). Most often screened patients were those with a driver mutation (MUT+; 51%, n = 234), stage III (63%, n = 289), and IV (43%, n = 199). 158 physicians (34%) used a prognostic classification to guide initial treatment decisions, and in 50%, ...Continue Reading
Citations
Jun 7, 2018·Journal of Medical Imaging and Radiation Oncology·Shalini K Vinod
Feb 14, 2019·Current Treatment Options in Neurology·Johannes KraftNicolaus Andratschke
May 28, 2019·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Valerio NardoneLuigi Pirtoli
Sep 12, 2019·Thoracic Cancer·Yu SaidaToshiaki Kikuchi
Aug 16, 2019·Current Opinion in Oncology·Riccardo SoffiettiRoberta Rudà
Dec 21, 2019·Neuro-oncology·Roberta Rudà, Riccardo Soffietti
Feb 20, 2020·Journal of Cancer Research and Clinical Oncology·Bruno MeduriUNKNOWN AIRO Giovani -Italian Association of Radiation Oncology-Young Members
Feb 20, 2020·Thoracic Cancer·Oscar ArrietaRafael Rosell
May 8, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Michael G MilliganAileen B Chen
Sep 21, 2018·Frontiers in Oncology·Gokoulakrichenane LoganadaneAntonin Levy
Sep 5, 2019·Frontiers in Immunology·Hua YouBozena Kaminska
Jul 23, 2020·Journal of Oncology·Qinge ShanZhehai Wang
Aug 25, 2018·Frontiers in Oncology·Ana TurkajSilvia Novello
Dec 10, 2019·Journal of Cancer Research and Clinical Oncology·Wang Li, Hong Yu
Jul 24, 2018·Therapeutic Advances in Neurological Disorders·Anna S Berghoff, Matthias Preusser
Jan 4, 2020·The European Respiratory Journal·Lizza E L HendriksThierry Berghmans
Nov 22, 2018·Frontiers in Oncology·Lizza E L HendriksAnne-Marie C Dingemans
Nov 14, 2018·Clinical & Experimental Metastasis·L M FürederA S Berghoff
Feb 1, 2020·Molecular Diversity·Disha PathakOm Silakari
Jan 5, 2021·Cancer Metastasis Reviews·Pierre-Yves BoriusIgor Latorzeff
Jan 14, 2021·International Journal of Molecular Sciences·Agnieszka Rybarczyk-KasiuchniczKatarzyna Stencel
Aug 24, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·F DhermainA Tallet
Feb 8, 2021·European Journal of Radiology·Shiori AmemiyaOsamu Abe
Feb 24, 2021·Journal of Neuro-oncology·Johannes KraftNicolaus Andratschke
Sep 15, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Antonin LevyUNKNOWN EORTC Lung Cancer Group (EORTC LCG)
Nov 2, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonin LevyUNKNOWN EORTC Lung Cancer Group (EORTC LCG)
May 6, 2021·Therapeutic Advances in Medical Oncology·Isabelle MonnetUNKNOWN GFPC 02-13 (METAL2) investigators
May 15, 2021·BioMed Research International·Yanli QuHong Yu
Jun 3, 2021·Cancers·Su-Hyun KimHo Jin Kim
Jun 29, 2021·PloS One·Julia FuchsSacha I Rothschild
Jun 15, 2021·Oncology Letters·Bingnan RenYufei Lian
Aug 11, 2021·Cancer Medicine·Mohammed SafiJiwei Liu
Nov 23, 2021·The British Journal of Radiology·Sophie H A E DerksMarion Smits